Home > Boards > US OTC > Delisted > World Surveillance Group Inc (fka WSGI)

You're right: I didn't address core business specifically,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Caradoc Member Profile
Member Level 
Followed By 6
Posts 667
Boards Moderated 0
Alias Born 06/13/00
160x600 placeholder
Coca-Cola Sees FX Helping This Year, Hurting Next Year -- Currency Comment
By Colin Kellaher
Kaival Brands Shares Rise 90% Premarket After FDA Stay of Bidi Vapor Products Denial Order
Monopar Therapeutics Shares Rise 12% Premarket After Patient Dosing
U.K. DMO Cuts Net Financing Requirement, Gilt Remit
Concerns About High U.S. Inflation May Be Overblown; Hawkish Talk by Two Federal Reserve Governors
GlaxoSmithKline 3Q Net Profit Fell Slightly But Beat Expectations; Raises 2021 Adjusted EPS View -- Update
UK Treasury Chief Sets New Tax, Spending Plans
Norfolk Southern 3Q Earnings Rise
Icahn Launches $75/Share Tender Offer for Southwest Gas
Bio-Path Shares Up Premarket After FDA Trial Clearance
Hertz, Uber Partner to Add Up to 50,000 Teslas to Uber Network by 2023
General Dynamics 3Q Revenue Rises on Higher Aerospace, Marine Sales
Kraft Heinz Raises 2021 Outlook
Novatek 3Q Net Profit Rose Significantly
GlaxoSmithKline 3Q Net Profit Fell Slightly; Raises 2021 Adjusted EPS View
European Companies Anticipate Supply Chain Issues Will Stretch Into 2022
Bristol Myers Squibb Narrows Full-Year Earnings Guidance
Bristol-Myers Squibb Posts 3Q Sales Growth as R&D Spending Rises
Kraft Heinz 3Q Profit Rises; Company Deals With Inflationary Pressures
Santander Is Expected to Release Part of Its Pandemic-Related Provisions in 4Q
Top Company News of the Day
McDonald's Quarterly Sales, Earnings Surpass Street Views
Boston Scientific Tweaks Full-Year Guidance to Narrow Range
Boston Scientific Swings to 3Q Profit; Sales Grow
BASF Raises Guidance After Weathering Supply Bottlenecks in 3Q -- Update
Caradoc Member Level  Tuesday, 05/24/05 02:21:20 AM
Re: lowtrade post# 2440
Post # of 44374 
You're right: I didn't address core business specifically, just as what gets us to profitability and continues to contribute to that profitability as strat revenues kick in. I suppose I could have mentioned that the core business will itself increase during 2006 and 2007, but assessment of 2008 and beyond remains the same: a boring numbers game with no need to jump out and back in as I sit back and collect dividend checks. At that point, pps will be of interest only because it determines margin available to make quick doubles in pennies.

Speaking of which, I'm ticked that Schwab won't allow margin on GTE until they receive the actual shares. This already limited the amount of OSFT I was able to buy this morning and kept me from being able to get into AMRE at all. Ditto, it's going to keep me from being able to take advantage of today's dip in HISC.

Regards,

Caradoc


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences